DrugMonitor™ Anti-Secukinumab Antibody (VS-1224-YC1069)
CAT#: VS-1224-YC1069
Secukinumab is an immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and other joint inflammatory disorders. The DrugMonitor™ Anti-Secukinumab Antibody (VS-1224-YC1069) is an anti-drug antibody (ADA) against Secukinumab. This drug-based antibody is raised in mice immunized with the Secukinumab. The anti-Secukinumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Secukinumab in samples.
Specifications
- Host Animal
- Mouse
- Specificity
- Secukinumab
- Target
- Secukinumab
- Immunogen
- Secukinumab
- Type
- Mouse IgG
- Species Reactivity
- Human
- Purity
- >95%
- Purification
- Protein G
- Applications
- ELISA, PK/PD, ADA control
- Format
- Liquid
- Concentration
- Batch-dependent
- Buffer
- PBS, pH 7.4
- Preservative
- No preservatives
- Storage
- Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
- Generic name
- Secukinumab
- Drug Weight
- 151000.0 Da
- Formula
- C₆₅₈₄H₁₀₁₃₄N₁₇₅₄O₂₀₄₂S₄₄
Customer Review
There are currently no Customer reviews or questions for VS-1224-YC1069. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
See other products for "Secukinumab"
Afuco™ Anti-IL17A ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-069)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL17A. It is a human monoclonal antibody designed for the treatments of uveitis, rheumatoid arthritis, and psoriasis. It targets member A from the cytokine family of interleukin 17.
Popular Products
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: Inhib, Cyt
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: ELISA, IHC, FC, IP, IF, BL
Application: ELISA, Inhib, FuncS
Application: ELISA, Neut, FuncS
Application: EM, ELISA, ICC, IHC-Fr, IHC-P, WB
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.